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Abstract
The human immunodeficiency virus type-1 (HIV-1) fusion peptide (FP) functions as a non-constitutive membrane anchor that translocates
into membranes during envelope glycoprotein-induced fusion. Here, by means of infrared spectroscopy (IR) and of various bilayer-
perturbation assays, we describe the peptide conformations that are accessible to its membrane-bound state and the transitions occurring
between them. The peptide underwent a conformational transition from a predominantly a-helical structure to extended h-type strands by
increasing peptide concentration in 1-palmitoyl-2-oleoylphosphatidylglycerol (POPG) vesicles. A comparable transition was observed at a
fixed 1:100 peptide-to-lipid ratio when calcium was added to vesicles containing prebound a-helical peptide. Cation binding induced an
increase in the amount of H-bonded carbonyls within the interfacial region of POPG. Calcium-promoted a!h conversion in membranes
correlated with the closure of preformed lytic pores and took place in dispersed (nonaggregated) vesicles doped with poly(ethylene glycol)–
lipid conjugates, showing that the conformational transition was independent of vesicle aggregation. We conclude that the target membrane
conditions modulate the eventual structure adopted by the HIV-1 FP. Conformational polymorphism of the inserted peptide may contribute to
the flexibility of the fusogenic complex during the fusion reaction cycle, and/or may be related to target membrane perturbation at the fusion
locus. D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
In human immunodeficiency virus type-1 (HIV-1), the
approximately 25 amino acid-long fusion peptide (FP) is
located at the N-terminus of the gp41 transmembrane
subunit of the envelope protein [1,2]. Current models
postulate that this long hydrophobic and conserved region
represents an additional membrane domain that transfers
into the target cell membrane during gp41-mediated fusion
[3,4]. Mutational analysis supports direct involvement of
FP in the fusion reaction [5–7]. Important sequence
features related to function include the presence of the
LFLGFL interfacial segment, probably involved in promot-
ing spontaneous transferring into target membranes, and
the occurrence of six Gly and five Ala residues which
suggests an intrinsic high degree of conformational plasti-
city [1,8–10].
Conformational flexibility is not unexpected given the
different folding states that HIV-1 FP is presumed to adopt
during gp41-mediated fusion. The prevailing hypothesis
states that HIV-1 fusion cascade starts when a gp120 surface
subunit interacts with receptor and coreceptors (for recent
reviews, see: Refs. [3,4,11]). During the process, the trans-
membrane gp41 subunit undergoes structural rearrange-
ments, notably the formation and/or reorientation of a
triple-stranded a-helical coiled-coil domain, thought to bring
about exposure of the previously cryptic FP in the vicinity of
the target membrane. The intermediate structure connecting
viral and target cell membranes would subsequently act as a
collapsible device that would reorganize into a six-helix
bundle, or trimeric hairpin, and eventually juxtapose coupled
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membranes. Thus, according to this mechanism, the FP
sequence would (a) be initially folded as a part of the gp41
ectodomain globular structure, (b) then be transiently
exposed to water at the tip of the triple stranded coiled-coil,
(c) afterwards be inserted as an anchor into the target
membrane, and (d) finally form an active part of a fusogenic
complex that perturbs bilayers to open a fusion pore.
The ability of the HIV-1 FP sequence to adopt different
structures has been confirmed by numerous experiments
using synthetic sequences and model membranes (reviewed
in: Refs. [8–10], see also: Ref. [12]). We described a system
consisting of negatively charged 1-palmitoyl-2-oleoylphos-
phatidylglycerol (POPG) vesicles, in the presence or
absence of divalent cations, as targets for the FP [13]. In
that previous work, we reported independent evidence for
peptide-induced mixing of bilayer lipids, for mixing of
aqueous vesicle contents, and for the occurrence of an
irreversible increase in vesicle size. To observe fusion
induced by the peptide, divalent cations were required in
the medium. We caution that divalent cations alone did not
induce any vesicle fusion in the concentration range used in
those studies. Our experimental approach further allowed
the assignment of distinct membrane-bound peptide struc-
tures to specific perturbations. In the absence of cations,
leakage of contents was promoted by peptides adopting an
a-helical conformation, whereas fusion was promoted in the
presence of cations by extended h-strands [13,14]. The
latter structure was afterwards shown to be prevalent in
electrically neutral dioleoylphosphatidylcholine (DOPC):
dioleoylphosphatidylethanolamine (DOPE):cholesterol
(Chol) vesicles, even in the dispersed unfused liposomes
containing low peptide doses [15]. For comparison, using
identical sample preparation protocols, we found mainly a-
helix in pure POPG liposomes at 1:65 peptide-to-lipid ratio
[13], and mainly h-strand in neutral DOPC:DOPE:Chol
vesicles at 1:800 peptide-to-lipid ratio [15]. Infrared reflec-
tion–absorption spectroscopy data confirmed the adoption
by the peptide of a main h-sheet structure in a single mono-
layer of neutral lipids [16]. Therefore, adoption of a partic-
ular conformation seemed to depend on the nature of the
membrane matrix rather than on artefactual production by
peptide dose or membrane aggregation.
Recent solid-state nuclear magnetic resonance (SS-
NMR) results by the group of Weliky [12] provide new
experimental evidence for an extended h-strand conforma-
tion of the membrane-bound HIV-1 FP under fusion-induc-
ing conditions. These authors found that the N-terminal and
central regions of the peptide were well structured as h-
strands in membranes composed of a lipid mixture mimick-
ing target T-cell membranes. Vesicles composed of that
mixture were readily fused by the peptide under the SS-
NMR measuring conditions. Thus, the findings in that work
further emphasize the putative functional relevance of the
extended peptide structure.
In the present study, we report on an important observa-
tion, namely the conversion of membrane-bound HIV-1 FP
a-helices into h-strands. Conversion occurs after increasing
peptide loads in membranes, but also at a fixed low peptide
dose after addition of calcium. We exploit this latter effect to
further investigate the possible relevance in HIV-1 fusion of
the different FP membrane structures. Our results support
the notion that the HIV-1 FP is conformationally polymor-
phic in dispersed membranes, a property susceptible to be
modulated by bilayer conditions such as surface compres-
sion or polar head group conformation. This observation
may be of physiological relevance if, as proposed, intrinsic
monolayer curvatures change during the fusion reaction
mediated by gp41.
2. Materials and methods
N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidyletha-
nolamine (N-NBD-PE), N-(lissamine Rhodamine B sulfo-
nyl)phosphatidylethanolamine (N-Rho-PE), distearoylphos-
phatidylethanolamine-poly(ethylene glycol) [MW of
poly(ethylene glycol) f 2000] (PEG-PE) and 1-palmi-
toyl-2-oleoyl-phosphatidylglycerol (POPG) were purchased
from Avanti Polar Lipids (Birmingham, AL, USA). N-(5-
dimethylaminonaphtalene-1-sulfonyl)-1,2-dihexadecanoyl-
sn-glycero-3-phosphoethanolamine (DNS-DHPE), 8-ami-
nonaphtalene-1,3,6-trisulfonic acid sodium salt (ANTS)
and p-xylenebis(pyridinium)bromide (DPX) were from
Molecular Probes (Junction City, OR, USA). Tetrahydro-
furane (THF), D2O and Triton X-100 were obtained from
Sigma (St. Louis, MO, USA). All other reagents were of
analytical grade. The sequence representing the N-terminus
of the HIV gp41, HIV-1 FP, AVGIGALFLGFLGAAGSTM-
GARS and its fluorescent derivative containing the F8W
substitution were synthesized as their C-terminal carboxa-
mides and purified (estimated homogeneity > 90%) by
Quality Controlled Biochemicals (Hopkinton, MA, USA).
Peptide stock solutions were prepared in dimethylsulfoxide
(DMSO, spectroscopy grade).
Large unilamellar vesicles (LUV) were prepared accord-
ing to the extrusion method of Hope et al. [17] in 5 mM
Hepes, 100 mM NaCl (pH 7.4). Lipid concentrations of
liposome suspensions were determined by phosphate anal-
ysis [18]. Mean diameter of vesicles was 120 nm as es-
timated by quasielastic light scattering using a Malvern Zeta-
Sizer instrument.
Release of vesicular contents to the medium was moni-
tored by the ANTS/DPX assay. LUV containing 12.5 mM
ANTS, 45 mM DPX, 20 mM NaCl and 5 mM Hepes [19]
were obtained by separating the unencapsulated material by
gel filtration in a Sephadex G-75 column eluted with 5 mM
Hepes, 100 mM NaCl (pH 7.4). Osmolarities were adjusted
to 200 mosM in a cryoscopic osmometer (Osmomat 030,
Gonotec, Berlin, Germany). Fluorescence measurements
were performed by setting ANTS emission at 520 nm and
excitation at 355 nm. A cutoff filter (470 nm) was placed
between the sample and the emission monochromator. 0%
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leakage corresponded to the fluorescence of the vesicles at
time zero; 100% leakage was the fluorescence value ob-
tained after addition of Triton X-100 (0.5% v/v).
Entry of solutes into vesicles was evaluated, through the
selective reduction of the NBD probe residing in the inner
leaflet of vesicle membranes, according to the method
described by McIntyre and Sleight [20]. Vesicles symmetri-
cally labeled with N-NBD-PE (0.6 mol%) were incubated
with peptide for 30 min. Then dithionite (10 mM) was
added to peptide–vesicle mixtures. Degree of vesicle per-
meabilization was inferred comparing the percentage of
reduced NBD in peptide-treated and untreated vesicles.
Percentage of NBD reduction was calculated following the
equation:
% Reduced NBD ¼ ½ðFf  F0Þ=ðF100  F0Þ  100 ð1Þ
where F0 corresponds to the NBD fluorescence value after
dithionite addition to untreated vesicles, Ff is the final
fluorescence after incubation with peptide and dithionite,
and F100 is the fluorescence value of solubilized vesicles
incubated with dithionite.
Membrane lipid mixing was monitored using the reso-
nance energy transfer (RET) assay, described by Struck et
al. [21]. The assay is based on the dilution of N-NBD-PE
and N-Rho-PE. Dilution due to membrane mixing results in
an increase in N-NBD-PE fluorescence. Vesicles containing
0.6 mol% of each probe were mixed with unlabeled vesicles
at 1:4 ratio. The NBD emission was monitored at 530 nm
with the excitation wavelength set at 465 nm. A cutoff filter
at 515 nm was used between the sample and the emission
monochromator to avoid scattering interferences. The fluo-
rescence scale was calibrated such that the zero level
corresponded to the initial residual fluorescence of the
labeled vesicles and the 100% value to complete mixing
of all the lipids in the system. The latter value was set by the
fluorescence intensity of vesicles, labeled with 0.12 mol%
each of the fluorophores, at the same total lipid concen-
tration as in the fusion assay.
Fluorescence energy transfer from peptide–Trp to the
surface fluorescent probe DNS-DHPE was measured as in
Refs. [22,23]. 6.25 mol% of DNS-DHPE probe was
included in the target vesicle composition (0.25 mM).
Lipid–peptide mixtures were incubated at room temperature
for 30 min before data acquisition. Corrected spectra were
recorded in a Perkin Elmer LS-50B spectrofluorimeter with
excitation set at 280 nm and slits of 5 nm for both excitation
and emission. The efficiency of energy transfer (E) was
determined according to Stryer [24] from the relative
fluorescence intensity of the Trp in the absence (Q0) and
presence (QT) of DNS-DHPE in the vesicles as:
E ¼ 1 ðQT=Q0Þ ð2Þ
Specific labeling of bilayer outer-leaflets was accomplished
as described in Ref. [23]. Briefly, vesicles were incubated
for 15 min with externally added DNS-DHPE (3.75 mol%
with respect to total lipid in vesicles) from a THF solution (5
mM). Further exchange of external buffer at 4 jC through
gel filtration on a Sephadex G-75 column rendered vesicles
asymmetrically labeled in their external monolayer with the
fluorescent DNS probe.
Infrared spectroscopy (IR) measurements were con-
ducted essentially as described in Refs. [13–15]. Membrane
samples consisted of floated peptide– lipid complexes
obtained after ultracentrifugation in D2O buffer. Solvent
samples were also obtained from the supernatant fraction
not containing lipid or peptide and subsequently used as
background controls. Infrared spectra were recorded in a
Nicolet 520 spectrometer equipped with an MCT detector.
Samples were placed between two CaF2 windows separated
by 50 Am spacers. One thousand scans (sample) and 1000
scans (reference) were taken for each spectrum, using a
shuttle device. Spectra were transferred to a computer where
solvent subtraction and band-position determinations were
performed using GRAMS software (Galactic) as previously
reported [25].
3. Results
The HIV-1 FP was previously shown to exist in POPG
membranes in predominantly a or h conformations, accord-
ing to the experimental conditions [2,13]. In the present
work, we have used an analog that contains a Trp residue
replacing Phe in position 8 and retains its full fusogenic
capacity [16]. The presence of the Trp residue allowed a
direct estimation of the peptide doses in the membrane under
our experimental conditions. To verify that this variant re-
produced an equivalent conformational behavior in solution
and in POPG membranes, its structures were determined by
means of IR. Similarly to the parental HIV-1 FP sequence,
the F8W analog peptide adopted a main extended conforma-
tion in solution, an a-helical structure in pure POPG vesicles,
and again h-like extended strands when the latter vesicles
were preincubated with 5 mM calcium before peptide ad-
dition (data not shown).
Thus, the intrinsically fluorescent variant was a suitable
tool to investigate the parameters that govern the adoption
of different structures by the HIV-1 FP, since it allowed
simultaneous monitoring of structure and peptide dose in the
membrane. This was particularly useful to infer the effect of
increasing peptide doses on the structures adopted by the
peptide in POPG LUV. Gp41-mediated fusion is postulated
to occur within defined spots of the interacting membranes,
as promoted by preformed high-order complexes [26].
Therefore, it has been proposed that in this physiological
situation, the local concentration of inserted FPs in the target
membrane is relatively high [10]. As shown by IR spectra in
Fig. 1A, increasing peptide loads in POPG LUV correlated
with an increment in the amide-I peak corresponding to
aggregates of extended structure. Note that the samples had
been freed from unbound peptide by centrifugation (flota-
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tion) before the spectroscopic measurements (see Materials
and Methods). These results are consistent with former IR
data obtained by Rafalski et al. [2] and Mobley et al. [27] in
dried and dried-wetted multilayers, respectively. The leak-
age and intervesicular lipid mixing results shown in Fig. 1B
revealed certain activation of the latter process only at the
highest loads tested (>1:30 peptide/lipid mole ratios),
whereas vesicles were efficiently permeabilized at 1:100
peptide-to-lipid ratio where almost pure helical conforma-
tion was observed (see also Table 1).
The high peptide loads required in POPG LUV to
promote the a!h conformational transition make difficult
any clear distinction between localized membrane perturba-
tions, specifically induced by the FP sequence, and unspe-
cific processes due to peptide-mass transfer to the
membrane. For instance, at extremely high peptide concen-
trations, lipids might exchange between aggregated vesicles
through processes other than fusion. This fact prompted us
to explore the ability of calcium to induce a similar
transition in situ at the low peptide doses at which the
helical conformation was predominant. To that end, we first
characterized the structural effect of adding the cation to
preincubated peptide–lipid mixtures (Fig. 2). We note that
in comparison to the experimental protocols used in pre-
vious works [13,14], this was a new condition in the sense
that here we explored the effect of calcium added to peptides
prebound to POPG LUV, that is, already in an a-helical
structure. The spectra displayed in Fig. 2A, obtained before
Table 1
Main IR band components and adopted secondary structures by HIV-1 FP







10:1 1625, 1651, 1687 a-helix, h-sheet
50:1 1652 a-helix
100:1 1652 a-helix
100:1 +Ca2+ 1626, 1652, 1688 a-helix, h-sheet
100:1 (Ca2+ ) 1625, 1687 h-sheet
100:1 PEG-PE 1651 a-helix
100:1 PEG-PE (Ca2+) 1626, 1687 h-sheet
a ‘‘ +Ca2 + ’’ indicates that the cation was added to preformed peptide–
vesicle complexes (final concentration, 5mM) while ‘‘(Ca2+)’’ corresponds
to samples containing 5 mM calcium before the addition of peptide. ‘‘PEG-
PE’’ indicates that vesicles contained this lipid at 5 mol% concentration.
Fig. 2. Conformational transition induced by addition of calcium on HIV-1
FP bound to POPG LUV. (A) IR spectra of the peptide bound to POPG
vesicles. Curve a: Peptide and vesicles were incubated for 30 min at a
peptide-to-lipid ratio of 1:100, before being subjected to flotation in D2O
buffer. Curve b: Peptide and vesicles were incubated for 30 min at a
peptide-to-lipid ratio of 1:100 and then calcium was added (final con-
centration, 5 mM). The mixture was further incubated for 30 min before
flotation. (B) Inhibition of FP-induced leakage by calcium. Leakage was
measured as a function of time (a). In curve (b), the cation (final con-
centration, 5 mM) was added at the time indicated by the arrow. Peptide-to-
lipid ratio was 1:100.
Fig. 1. Structures adopted by HIV-1 FP (F8W analog) and induced POPG
membrane perturbations as a function of the peptide dose. (A) IR spectra of
the peptide bound to POPG vesicles at increasing peptide-to-lipid ratios. (B)
Final extents of leakage (circles) and intervesicular lipid mixing (squares)
as a function of peptide to lipid mole ratio. Lipid concentration was
constant (100 AM). Inset: extents of lipid mixing at the highest peptide-to-
lipid ratios tested.
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and after calcium addition, demonstrated the existence of an
a!h conformational transition. Peptide membrane-loads in
both samples were simultaneously determined as described
[16]. In accordance with results reported by Mobley et al.
[27], we found that the peptide bound almost quantitatively
to POPG LUV under our experimental conditions. More-
over, the initial membrane peptide-load did not appreciably
change in the presence of the cation (not shown). Thus, the
observed conformational transition occurred in membranes
at invariant peptide concentration. Data in panel B demon-
strate that calcium addition also arrested the ongoing leak-
age process induced by the peptide, suggesting that the
conformational transition to the h-type structure causes the
inhibition of pore formation. The fast effect of calcium on
the process suggests that the transition occurred almost
simultaneously to binding of the cation by the phospholipid.
IR provides useful information on Ca2+ -induced confor-
mational changes in phospholipids [28–30]. In particular,
the carbonyl stretching vibrations [31], report on the con-
ditions in the membrane–water interface region. The spec-
trum of pure POPG dispersed in D2O buffer (Fig. 3A)
shows that the carbonyl stretching region (1800–1700
cm1) was composed of two bands centered at 1743 and
1725 cm1, corresponding to non-hydrogen bonded and
monohydrated carbonyl groups, respectively [31]. Addition
of calcium to these samples induced the appearance of new
and narrower component bands, centered at 1738 and 1725
cm1, most likely arising from the phospholipid population
interacting with the cation. In addition, a lower frequency
band at 1704 cm1 became evident. The latter vibration has
been assigned to CjO groups forming hydrogen bonds
with two molecules of water [31]. Parallel spectra in panel B
show that, in the absence of calcium, the carbonyl stretching
bands in the peptide–lipid complexes isolated by flotation
were similar to those observed in hydrated POPG samples.
In presence of the cation, floated peptide–lipid complexes
showed sharp 1736 and 1727 cm1 components together
with the lower frequency 1703 cm1 band.
The shift of f 6 cm1 in the maximum absorbance of
the dehydrated carbonyl groups suggests the existence of a
conformational change induced by calcium in the interfacial
region of POPG. Moreover, the band narrowing in the
presence of the cation would be consistent with a higher
degree of immobilization in this configuration. This effect is
comparable to the one observed in phosphatidylserine
membranes where calcium has been shown to induce a
rigid conformation of the carbonyls, even though these
moieties remain hydrated [28–30]. The change induced
by calcium in the POPG system also resulted in a relative
increase of the monohydrated carbonyls (1727 cm1) with
respect to dehydrated species (1736 cm1). This fact
together with the appearance of disolvated species (1703
cm1) suggests a higher degree of hydrogen-bonded CjO
groups in cation-treated samples.
The calcium-induced changes were not only affecting the
peptide before the assembly of POPG-embedded pores (Fig.
2B), but could also act on preformed pores. This was shown
in experiments in which the closure of preformed pores was
investigated in fully permeabilized vesicles. The latter were
obtained by incubating POPG LUV with a peptide dose
inducing 100% leakage (Fig. 4A). Further size-distribution
determination indicated that untreated and permeabilized
vesicles had the same average size. To assay solute entry
into these vesicles, we measured the percentage of NBD
reduction in POPG/NBD-PE (99.4:0.6 mole ratio) by exter-
nally added dithionite. In symmetrically labeled vesicles,
this compound reduced approximately 60% of NBD as
judged from the decrease in fluorescence intensity (Fig.
4B), indicating specific reduction of the probe residing in
the external membrane leaflet [20]. Thus, we considered this
value as the zero level of entry, whereas complete reduction
in solubilized vesicles was taken as the 100% value. Full
permeabilization of vesicles treated with peptide as in panel
A was evidenced from the capacity of dithionite to reduce
100% of the NBD in these samples (curve b in panel B).
Data in Fig. 4C are consistent with almost complete inhib-
ition of solute entry by preincubation of permeabilized
vesicles with calcium. Moreover, addition of the cation in
the midst of solute entry arrested the process. We conclude
that HIV-1 FP pores established in POPG LUV may close
after addition of calcium.
Fig. 3. Infrared Fourier self-deconvoluted spectra of POPG in the CjO
stretching region. (A) Multilayers hydrated in D2O buffer: (a) pure POPG;
(b) POPG–calcium. (B) Floated peptide–POPG LUV complexes: (a) in the
absence of calcium; (b) in the presence of 5 mM calcium.
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Vesicle aggregation had no effect on the conformational
transition, that is, the transition could develop in isolated
liposomes. This was demonstrated by using polyethylene
glycol-grafted POPG vesicles. PEG moiety has been dem-
onstrated to act as a steric barrier that hinders bilayer–
bilayer contacts [32,33]. We used a polymer containing 45
ethylenes per unit (MW f 2000) which depending on its
density may project from 35 to 160 A˚ from the bilayer
surface [34]. When this compound was included in the
liposome formulation, the capacity of the HIV-1 FP to
induce intervesicular lipid mixing in the presence of calcium
was inhibited (Fig. 5). Peptide-induced mixing of mem-
branes was reduced by more than 50% when the liposomes
contained 1 mol% PEG-PE, and 5 mol% PEG-PE arrested
the process almost completely. The lipid mixing levels
detected under the latter conditions were even below those
detected in the absence of calcium. Control experiments
demonstrated that peptide doses in the membrane did not
change after inclusion of PEG-PE. Moreover, determination
of vesicle size distributions showed that the mean diameter
did not change appreciably. Thus, in POPG/PEG-PE (95:5
mole ratio) vesicles, the peptide capacity to induce aggre-
gation and fusion was inhibited.
In contrast, the peptide efficiently permeabilized those
vesicles (Fig. 6). Results in Fig. 6A demonstrate that the
peptide induced leakage from POPG/PEG-PE (95:5 mole
ratio) and POPG LUV to comparable levels. But even more
important, in the presence of calcium, leakage was similarly
reduced in both types of vesicles indicating that the cation
interfered with this process independently of the induction of
membrane aggregation and/or fusion. Results in panel B
reflect that addition of calcium also arrested ongoing leakage
in POPG/PEG-PE (95:5 mole ratio) LUV, a fact consistent
with a structural transition taking place in these dispersed
bilayers. IR actually confirmed the existence of the a!h
structural transition in POPG/PEG-PE (95:5 mole ratio)
membranes (Table 1). The peptide bound to POPG/PEG-
Fig. 5. Intervesicular mixing of lipids induced in presence of 5 mM calcium
by the HIV-1 FP. POPG (filled circles), POPG:PEG-PE (99:1 mole ratio)
(squares) and POPG:PEG-PE (95:5 mole ratio) (inverted triangles). Empty
circles correspond to the FP effect in POPG vesicles in the absence of
calcium. Final extents of the process were plotted as a function of the lipid-
to-peptide ratio. Lipid concentration was fixed to 100 AM in all cases.
Fig. 4. Closure of preformed HIV-1 FP pores after addition of calcium. (A)
Peptide-induced leakage of POPG vesicles (ANTS/DPX assay) as a
function of time. The peptide-to-lipid ratio was 1:25. (B) NBD reduction
by dithionite. Curve a: POPG:NBD-PE vesicles treated with dithionite
(added at time=60 min); curve b: POPG:NBD-PE vesicles preincubated
with the peptide for 1 h under conditions in panel A, and then treated with
dithionite. (C) Entry of solutes (dithionite assay) into permeabilized POPG
vesicles. Vesicles were incubated with the peptide for 1 h (conditions as
described in panel A) before dithionite addition. Curve a: permeabilized
POPG:NBD-PE vesicles; curve b: calcium (final concentration, 5 mM) was
added after dithionite at the time indicated by the arrow; curve c: per-
meabilized POPG:NBD-PE vesicles incubated with 5 mM calcium before
dithionite addition.
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PE vesicles showed a main IR absorption band at 1651 cm1
that converted into 1626 and 1687 cm1 upon addition of
calcium to mixtures, consistent with mainly a-helical and
extended structures before and after addition, respectively.
Of note, the observation of leakage in the presence of
calcium in the dispersed POPG/PEG-PE vesicles (Fig. 6A),
at the doses at which membrane mixing was detected in pure
POPG vesicles, further supports the notion introduced in
previous works [15,35] that the h-type structure may induce
a type of membrane perturbation that causes permeabiliza-
tion in isolated vesicles, but also their subsequent aggrega-
tion and fusion. In summary, results in Fig. 6 suggest that
calcium promoted the a!h structural transition of the
peptide by altering the conditions of the isolated bilayers
and not through the induction of interbilayer contacts.
Moreover, experimental results in Fig. 7 show that
calcium induced a superficial location of the peptide. The
locations of the helical and extended conformations in the
POPG bilayer were investigated through resonance energy
transfer of the Trp-8 residue to the surface-residing dansyl
moiety of the DNS-DHPE probe [22]. As shown in Fig. 7,
both peptide conformations transferred energy to DNS-
DHPE in symmetrically labeled LUV rather effectively
[transfer efficiency (E) was 0.55 at 1:100 peptide/lipid
ratio]. In comparison, when LUV were asymmetrically
labeled in the outer-leaflet, energy transfer by the a-helical
conformation was very much reduced (E = 0.1 at 1:100
peptide/lipid ratio) while the h-type structure was almost
equally good as donor (E = 0.38 at 1:100 peptide/lipid
ratio). The dansyl moiety of DNS-DHPE is located at the
edge of the lipid–water interface in the vesicles [36]. The R0
distance calculated for the dansyl–Trp couple is approx-
imately 17 A˚ [37]. Assuming a bilayer thickness of 50 A˚,
the low energy transfer observed for the a-helical confor-
mation in asymmetrically labeled LUV is likely to arise
from a distant location of the Trp residue from the outer
monolayer interface, a fact consistent with the deep pene-
tration of the N-terminal section of the peptide [38]. In
contrast, the comparable E values in both types of LUV
observed for the h-type structure is consistent with an
interaction mostly restricted to the outer membrane mono-
layer [16].
4. Discussion
In this work, we describe two factors that modulate the
conformations accessible to the HIV-1 FP associated to
POPG membranes, that is, peptide load and cation binding.
The peptide adopted a stable helical conformation that could
be converted into an extended h-type structure by addition
of calcium. The use of intrinsically fluorescent peptide
analogs allowed us to determine that the latter process
occurred without a change in the amount of peptide bound
Fig. 7. Intrinsic fluorescence of FP analog containing a F8W substitution
interacting with unlabeled POPG vesicles (L0), and POPG vesicles labeled
with DNS-PE in both membrane leaflets (LS) or specifically in the external
leaflet (LA). Experiments were carried out in presence and absence of 5
mM calcium as indicated in the panels. Peptide-to-lipid ratio was 1:100 and
lipid concentration 100 AM in all measured samples.
Fig. 6. Leakage of vesicular contents (ANTS/DPX assay) induced by the FP
in POPG:PEG-PE (95:5) vesicles. (A) Final extents of the process as a
function of the lipid-to-peptide ratio. Filled and empty circles correspond to
experiments done in the absence and the presence (5 mM) of calcium,
respectively. (B) Kinetics of leakage at 1:100 peptide-to-lipid ratio. In curve
b, calcium was added at the time indicated by the arrow.
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to membranes. Importantly, the cation-driven structural
transition was observed to proceed in dispersed PEG-PE/
POPG vesicles. We conclude that FP may exist in h-
structures in isolated membranes and that these structures
may perturb bilayers and induce in them a state of fusoge-
nicity. Nevertheless, it should be pointed out that the model
system described here is still far from reflecting entirely the
in vivo complexity of the studied interaction, and that it
should be rather considered as a tool useful to get insights
into the structural behavior of the HIV-1 FP associated to
membranes.
4.1. FP membrane dose and adopted conformations
The dose-dependent conformational polymorphism of
HIV-1 FP in POPG membranes was first suggested by
Rafalski et al. [2] in dried multilayers. These authors found
that a-helical conformation and h-type structures predomi-
nated at 1:200 and 1:30 peptide-to-lipid ratios, respectively.
At a peptide-to-lipid ratio of 1:17, the peptide was able to
fuse POPG SUV (25% intervesicle lipid mixing). Our data in
this work confirm that also when the peptide was incorpo-
rated from the aqueous phase into POPG LUV, increasing
amounts in the bilayer resulted in an increased relative
amount of h-structure adopted by FP (Fig. 2 and Table 1).
The peptide also induced a certain amount of interLUV
mixing of lipids at the highest peptide-to-lipid ratios tested
(e.g., 10% at a 1:15 ratio). The higher levels of lipid mixing
detected in SUV as compared to LUV probably reflect the
intrinsic metastability of the former [39]. From our data, we
may conclude that there exists a correlation between the
ability of the HIV-1 FP to induce POPG LUV fusion and the
dose-dependent accumulation of h-type structure. The same
trend seems as well to operate in other lipid systems as
inferred from published data (reviewed in Ref. [9]).
4.2. Membrane conditions and adopted conformation
The presence of a h-type structure is required for
induction of fusion but it is not sufficient by itself. Rafalski
et al. [2] showed that the HIV-1 FP adopted an extended
structure in POPC membranes but was unable to fuse SUV
composed of this lipid. These authors interpreted the
requirement of POPG in this system as an indication of
the FP helical structures being involved in fusion. However,
we note that at the peptide-to-lipid ratios used in those
experiments (1:17), the FP also adopted a predominantly h-
type structure in POPG membranes . Therefore, it seems
more likely that fusogenicity of the same h-type peptide
may be modulated by the conditions in the membrane. In
fact, inclusion into phosphatidylcholine (PC) membranes of
phosphatidylethanolamine and cholesterol results in the
induction of 100% LUV fusion by the peptide [15]. In this
latter system, the adopted structure is extended for peptide-
to-lipid ratios ranging between 1:800 and 1:10. Two main
interrelated membrane factors may affect fusogenicity by
the peptide. First, the intrinsic tendency of juxtaposed
bilayers to fuse is modulated by the presence of non-
lamellar lipids such as phosphatidylethanolamine with neg-
ative spontaneous curvature [40]. Second, the fact that the
latter kind of lipids has a large apolar portion relative to their
polar moiety (cone-like lipids), may facilitate access of the
FP sequences to the interfacial region of the membrane
(discussed in Ref. [41]). These assumptions are also sup-
ported by recent SS-NMR spectroscopy results by Yang et
al. [12], indicating a greater structural order of the mem-
brane-bound h-strand in lipid mixtures mimicking target T-
cell plasma membrane. These authors found little depend-
ence of structural distribution on peptide-to-lipid ratios for
samples made of mixtures of lipids containing phosphati-
dylethanolamine and cholesterol, but a significant depend-
ence in a sample made of a single lipid.
A parallel line of evidence comes from the use of cations
to modulate POPG properties [13,14]. We found that under
conditions where the peptide was able to induce substantial
POPG LUV permeabilization, the adopted conformation in
membranes was mainly helical and no fusion was detected.
Addition of calcium to these samples caused closure of
pores and a conformational transition towards a predom-
inantly extended structure. Noteworthy, at peptide mem-
brane-doses inducing permeabilization as an a-helix, for
example, 1:100 peptide-to-lipid ratio, the extended struc-
tures formed after calcium addition showed no capacity to
perturb membranes. These latter structures required higher
doses of peptide in the membrane to perturb the bilayer
architecture. Moreover, according to our results, the
extended structures formed in dispersed (i.e., non-aggre-
gated) membranes were primarily lytic (see also, Refs.
[15,35]). Thus, the type of perturbation induced by the
extended structure at higher doses seems to be qualitatively
different from the one induced by the helical conformation.
While the former compromises the overall bilayer organ-
ization causing permeabilization and further allowing the
intermembrane mixing of constituent lipids, the latter estab-
lishes discrete structures through which solutes can cross the
membrane in both directions.
The effect of calcium on POPG appears to be relatively
similar to that caused by this cation on phosphatidylserine
membranes [28–30]. Calcium binding induces a change in
the polar head group conformation that becomes more rigid
[29,30] and a differential reduction of the polar head group
cross-sectional area [42], which may facilitate intrusion of
water molecules through the interfacial region of the mem-
brane. We propose that cation binding to POPG promotes
the a!h conformational transition of HIV-1 FP as a
consequence of its effects on the interfacial region of the
membrane. The superficial location of the peptide (Fig. 7)
might be favored by a head-group displacement similar to
that produced in systems containing non-lamellar lipids
[41]. In addition, the overall increase in hydrogen bonding
(Fig. 6) might better satisfy the stability requirements of h-
type strands immersed in the bilayer interface.
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4.3. Relevance for HIV-1 fusion
HIV-1 FP may exist in bilayers in one of two main
conformations, that is, lytic a-helices or interfacial h-strands,
depending on conditions such as peptide-to-lipid ratio,
membrane lipid composition, or concentration of divalent
cations. This conformational polymorphism may be phys-
iologically relevant. We envisage two non-mutually exclu-
sive hypotheses to explain the importance of peptide
plasticity in the gp41-mediated fusion process.
(1) Conformational polymorphism of the inserted HIV-1
FP might contribute to the flexibility of the fusogenic
complex during the fusion reaction cycle if, as suggested
by the ‘‘hairpin’’ model, the rod-shaped gp41 ectodomain
goes from a conformation in which its axis is perpendicular
to the target bilayer normal (inserted prefusion state or ‘‘pre-
hairpin’’) to a conformation that is mainly parallel to the
membrane interface (‘‘hairpin’’ structure) [3,4,11]. The
intrinsic assumption within this model is that the FP behaves
as a flexible anchor that alternates conformation and level of
insertion in the membrane.
(2) Adoption of two conformations might also be related
to induction of important membrane perturbations. Lytic
helical structures might form within the target membrane as
recently suggested in the new model of influenza hemag-
glutinin-mediated membrane fusion by Bonnafous and
Stegmann [43]. In principle, our data on the HIV-1 FP
would support the existence of such structures in the target
membranes. Formation of those lytic aggregates may pre-
cede the formation of gp41 complexes, with interfacially
located extended structures. Peptide aggregates interacting
superficially with the target membrane at the point of fusion
might promote distortion of the external monolayer [16,44].
This target-membrane perturbation would be localized at the
fusion point and might be absorbed by the virion membrane
closely apposed by the action of the ‘‘hairpin’’ structure. In
this view, the FP would play an active role in the fusion
process mediated by HIV-1 gp41.
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